Opendata, web and dolomites

ARM-B

The ARM-B skin-allergy diagnostics patch is a compact, easy to apply, low-cost allergy testing product.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ARM-B project word cloud

Explore the words cloud of the ARM-B project. It provides you a very rough idea of what is the project "ARM-B" about.

microgel    shaped    alternative    draws    minimising    microarray    patient    accredited    prevalent    arm    penetrating    innovation    quantitative    impedance    patients    nausea    specialist    alike    allogen    depths    advantages    ensures    prick    severity    millimetre    adverse    biosensor    healthcare    skin    engineered    markets    oriented    mm    ultra    outcomes    malaise    diagnostics    risk    mark    simplicity    segments    electrical    clinics    company    clinical    setting    tine    disc    allergen    pen    device    dataset    solution    acquires    market    extends    biotech    patch    applicable    innovating    reaction    epidermis    home    few    biosensors    pricks    consequence    raining    viz    therapist    minutes    microns    reactions    interpreted    structure    allergens    free    individual    picomole    vivo    panels    sensors    allergic    provides    collated    nl    microelectrode    panel    uses    intrusive    hundred    consultation    self    purified    practitioners    allergy    degree    stick    invasiveness    data    reliability    pain    register    offers   

Project "ARM-B" data sheet

The following table provides information about the project.

Coordinator
ALLOGEN BIOTECH LIMITED 

Organization address
address: 12 SEAFIELD ROAD CLONTARF
city: DUBLIN
postcode: D03YT25
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.allogenbiotech.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLOGEN BIOTECH LIMITED IE (DUBLIN) coordinator 50˙000.00

Map

 Project objective

Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARM-B" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARM-B" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Osto.Me (2020)

Ostomy Market Disruption: First Leak Proof Ostomy Appliance removing the need for Accessories in the Ostomy Market

Read More